Menu

USC President Steps Down in Wake of Gynecologist Scandal

An uproar over the university’s handling of sexual misconduct accusations led to C.L. Max Nikias’s resignation.  

May 29, 2018
Sukanya Charuchandra

C.L. Max NikiasFLICKR, DANIEL HINTON FOR DEPARTMENT OF DEFENSEFollowing a backlash over alleged sexual misconduct by a gynecologist at the school health center, C.L. Max Nikias, president of the University of Southern California (USC), stepped down late last week (May 25).

“We have heard the message that something is broken and that urgent and profound actions are needed,” Rick Caruso, a member of the USC Board of Trustees, says in a statement.

Nikias has been in office since 2010, leading the Los Angeles-based university through a period of enormous growth as it benefitted from a $6 billion donation. However, over the past few years, a series of scandals have gripped the establishment. The university’s response to the allegations against George Tyndall, the campus gynecologist for nearly 30 years, was the final nail in the coffin for Nikias’s tenure, according to The New York Times.

Following several complaints from students and staff spanning decades and an ensuing investigation that found Tyndall ’s behavior constituted sexual harassment, he was offered money to resign. Several women have filed lawsuits against Tyndall, according to USA Today, and reporting by the Los Angeles Times has sparked criticism from students, alumni, and faculty over the past few weeks. A letter asking Nikias to resign had garnered almost 500 signatures from faculty by Friday.

“We’re at a real crossroads for the university and this is the first step in starting over,” Ariela Gross, a law professor who led the faculty effort, tells The New York Times.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!